tiprankstipranks
Trending News
More News >
NewAmsterdam Pharma Company (NAMS)
NASDAQ:NAMS
US Market

NewAmsterdam Pharma Company (NAMS) Revenue

Compare
188 Followers

NewAmsterdam Pharma Company Revenue

NewAmsterdam Pharma Company had a revenue of 2.98M in the quarter ending Mar 31, 2025, with -76.68%. This bring the company's revenue in the last twelve months to 47.14M, Decreased 3.46%. In the fiscal year ending Dec 31, 2024, NewAmsterdam Pharma Company had annual revenue of 45.56M with 257.00% growth.
Revenue (ttm)
47.14M
Revenue Growth
P/S Ratio
45.56
Revenue/Employee
$670,044
Employees
68
Market Cap
$2.08B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
45.56M32.80M+257.00%
Dec 31, 2023
12.76M-83.14M-86.69%
Dec 31, 2022
95.91M+∞%
Dec 31, 2021
0.00
Dec 31, 2020
0.00
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis